Sibutramine

Chemical formula: C₁₇H₂₆ClN  Molecular mass: 279.848 g/mol  PubChem compound: 5210

Therapeutic indications

Sibutramine is indicated for:

Indication

Population group: only adults (18 - 65 years old)

Obesity

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Sibutramine is contraindicated in the following cases:

Contraindication

at least one of
Combined vocal and multiple motor tic disorder [de la Tourette]
MAO inhibitors
Hypertension
Ischaemic heart diseases
Congestive heart failure
Paroxysmal tachycardia
Peripheral vascular disease, unspecified

Transient cerebral ischaemic attacks and related syndromes
Stroke, not specified as haemorrhage or infarction
Thyrotoxicosis [hyperthyroidism]
Hepatic insufficiency
Renal failure
Phaeochromocytoma
Primary angle-closure glaucoma
Pregnancy
Lactation
Mental and behavioural disorders
Pregnancy
Lactation

Contraindication

Hyperplasia of prostate and additionally Retention of urine

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈